| 基因名 | 突变 |
|---|---|
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196754781A>G,c.50T>C,p.V17A |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196754761G>A,c.70C>T,p.R24W |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196754668C>T,c.163G>A,p.V55I |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196754661C>A,c.170G>T,p.G57V |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196751281A>C,c.380T>G,p.V127G |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196751206C>T,c.455G>A,p.R152H |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196744155G>A,c.719C>T,p.T240M |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196744084C>T,c.790G>A,p.D264N |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196743994G>A,c.880C>T,p.R294W |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196743239C>T,c.902G>A,p.R301H |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196742309C>T,c.1160G>A,p.R387H |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196742277C>T,c.1192G>A,p.V398M |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196742244G>A,c.1225C>T,p.R409W |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196742243C>T,c.1226G>A,p.R409Q |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196737616G>A,c.1283C>T,p.A428V |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196736575A>G,c.1439T>C,p.F480S |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196736546C>T,c.1468G>A,p.V490M |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196736516G>A,c.1498C>T,p.R500W |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196736515C>T,c.1499G>A,p.R500Q |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196736502A>C,c.1512T>G,p.C504W |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196735807C>T,c.1555G>A,p.V519M |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196735756C>T,c.1606G>A,p.V536M |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196735687C>T,c.1675G>A,p.A559T |
| MFI2(NM_005929,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,738aa) | g.3:196733596C>T,c.1762G>A,p.E588K |
| MFHAS1(NM_004225,malignant fibrous histiocytoma amplified sequence 1,1052aa) | g.8:8750244G>C,c.325C>G,p.L109V |
| MFHAS1(NM_004225,malignant fibrous histiocytoma amplified sequence 1,1052aa) | g.8:8749944G>T,c.625C>A,p.L209M |
| MFHAS1(NM_004225,malignant fibrous histiocytoma amplified sequence 1,1052aa) | g.8:8748306C>G,c.2263G>C,p.G755R |
| MFHAS1(NM_004225,malignant fibrous histiocytoma amplified sequence 1,1052aa) | g.8:8748032G>C,c.2537C>G,p.A846G |